- Home
- Publications
- Publication Search
- Publication Details
Title
Diabetes and COVID-19: The past, the present, and the future
Authors
Keywords
COVID-19, Diabetes, Pandemic, Morbidity, Mortality
Journal
METABOLISM-CLINICAL AND EXPERIMENTAL
Volume 121, Issue -, Pages 154814
Publisher
Elsevier BV
Online
2021-06-11
DOI
10.1016/j.metabol.2021.154814
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Diabetes, obesity, metabolism and SARS-CoV-2 infection: The end of the beginning
- (2021) Daniel J. Drucker Cell Metabolism
- Predictors of hospital discharge and mortality in patients with diabetes and COVID-19: updated results from the nationwide CORONADO study
- (2021) Matthieu Wargny et al. DIABETOLOGIA
- Characteristics of and Mortality Associated With Diabetic Ketoacidosis Among US Patients Hospitalized With or Without COVID-19
- (2021) Francisco J. Pasquel et al. JAMA Network Open
- Visceral adiposity, subcutaneous adiposity, and severe coronavirus disease-2019 (COVID-19): Systematic review and meta-analysis
- (2021) Raymond Pranata et al. Clinical Nutrition ESPEN
- Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target
- (2020) Haibo Zhang et al. INTENSIVE CARE MEDICINE
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- COVID-19 pandemic, coronaviruses, and diabetes mellitus
- (2020) Ranganath Muniyappa et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
- (2020) Alexandra C. Walls et al. CELL
- Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes
- (2020) Lihua Zhu et al. Cell Metabolism
- Obesity a Risk Factor for Severe COVID-19 Infection: Multiple Potential Mechanisms
- (2020) Naveed Sattar et al. CIRCULATION
- Exploring Diseases/Traits and Blood Proteins Causally Related to Expression of ACE2, the Putative Receptor of SARS-CoV-2: A Mendelian Randomization Analysis Highlights Tentative Relevance of Diabetes-Related Traits
- (2020) Shitao Rao et al. DIABETES CARE
- Outcomes in Patients With Hyperglycemia Affected by Covid-19: Can We Do More on Glycemic Control?
- (2020) Celestino Sardu et al. DIABETES CARE
- Newly diagnosed diabetes is associated with a higher risk of mortality than known diabetes in hospitalized patients with COVID ‐19
- (2020) Huiqing Li et al. DIABETES OBESITY & METABOLISM
- The Silver Lining to COVID-19: Avoiding Diabetic Ketoacidosis Admissions with Telehealth
- (2020) Anne L. Peters et al. Diabetes Technology & Therapeutics
- Managing New-Onset Type 1 Diabetes During the COVID-19 Pandemic: Challenges and Opportunities
- (2020) Satish K. Garg et al. Diabetes Technology & Therapeutics
- Obesity and SARS‐CoV‐2: a population to safeguard
- (2020) Mikiko Watanabe et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study
- (2020) Bertrand Cariou et al. DIABETOLOGIA
- Coronavirus Infections and Type 2 Diabetes—Shared Pathways with Therapeutic Implications
- (2020) Daniel J Drucker ENDOCRINE REVIEWS
- Pancreatic injury patterns in patients with COVID-19 pneumonia
- (2020) Fan Wang et al. GASTROENTEROLOGY
- Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area
- (2020) Safiya Richardson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy
- (2020) Giacomo Grasselli et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Predicting mortality due to SARS-CoV-2: A mechanistic score relating obesity and diabetes to COVID-19 outcomes in Mexico
- (2020) Omar Yaxmehen Bello-Chavolla et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Hypertension is associated with increased mortality and severity of disease in COVID-19 pneumonia: A systematic review, meta-analysis and meta-regression
- (2020) Raymond Pranata et al. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
- (2020) Fei Zhou et al. LANCET
- Obesity and impaired metabolic health in patients with COVID-19
- (2020) Norbert Stefan et al. Nature Reviews Endocrinology
- Clinical Characteristics of Covid-19 in New York City
- (2020) Parag Goyal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Does Coronavirus Disease 2019 Disprove the Obesity Paradox in Acute Respiratory Distress Syndrome?
- (2020) Ricardo J. Jose et al. Obesity
- Is Adipose Tissue a Reservoir for Viral Spread, Immune Activation, and Cytokine Amplification in Coronavirus Disease 2019?
- (2020) Paul MacDaragh Ryan et al. Obesity
- How diabetes management is adapting amid the COVID-19 pandemic
- (2020) Peter Ranscombe Lancet Diabetes & Endocrinology
- Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1α/Glycolysis-Dependent Axis
- (2020) Ana Campos Codo et al. Cell Metabolism
- Managing Hyperglycemia in the COVID-19 Inflammatory Storm
- (2020) Roma Gianchandani et al. DIABETES
- Body Mass Index and Outcome in Patients with COVID-19: A Dose-Response Meta-Analysis
- (2020) Raymond Pranata et al. DIABETES & METABOLISM
- Hyperglycemia at Hospital Admission Is Associated With Severity of the Prognosis in Patients Hospitalized for COVID-19: The Pisa COVID-19 Study
- (2020) Alberto Coppelli et al. DIABETES CARE
- Diabetes Epidemiology in the COVID-19 Pandemic
- (2020) Elizabeth Selvin et al. DIABETES CARE
- Admission fasting blood glucose predicts 30‐day poor outcome in patients hospitalized for COVID ‐19 pneumonia
- (2020) Bin Zhang et al. DIABETES OBESITY & METABOLISM
- Usefulness and Safety of Remote Continuous Glucose Monitoring for a Severe COVID-19 Patient with Diabetes
- (2020) Emi Ushigome et al. Diabetes Technology & Therapeutics
- A Pragmatic Approach to Inpatient Diabetes Management during the COVID-19 Pandemic
- (2020) Mary Korytkowski et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Impact of cerebrovascular and cardiovascular diseases on mortality and severity of COVID-19–systematic review, meta-analysis, and meta-regression
- (2020) Raymond Pranata et al. Journal of Stroke & Cerebrovascular Diseases
- Visceral fat shows the strongest association with the need of intensive Care in Patients with COVID-19
- (2020) Mikiko Watanabe et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Commentary: COVID-19 in patients with diabetes
- (2020) Michael A. Hill et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- New-Onset Diabetes in Covid-19
- (2020) Francesco Rubino et al. NEW ENGLAND JOURNAL OF MEDICINE
- Practical recommendations for the management of diabetes in patients with COVID-19
- (2020) Stefan R Bornstein et al. Lancet Diabetes & Endocrinology
- COVID-19 in people with diabetes: understanding the reasons for worse outcomes
- (2020) Matteo Apicella et al. Lancet Diabetes & Endocrinology
- COVID-19, type 1 diabetes, and technology: why paediatric patients are leading the way
- (2020) Thomas Danne et al. Lancet Diabetes & Endocrinology
- Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study
- (2020) Naomi Holman et al. Lancet Diabetes & Endocrinology
- Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study
- (2020) Emma Barron et al. Lancet Diabetes & Endocrinology
- Elevation of blood glucose level predicts worse outcomes in hospitalized patients with COVID-19: a retrospective cohort study
- (2020) Jianfeng Wu et al. BMJ Open Diabetes Research & Care
- The MERS-CoV Receptor DPP4 as a Candidate Binding Target of the SARS-CoV-2 Spike
- (2020) Yu Li et al. iScience
- Sitagliptin Treatment at the Time of Hospitalization Was Associated With Reduced Mortality in Patients With Type 2 Diabetes and COVID-19: A Multicenter, Case-Control, Retrospective, Observational Study
- (2020) Sebastiano Bruno Solerte et al. DIABETES CARE
- Type 2 Diabetes and COVID-19–Related Mortality in the Critical Care Setting: A National Cohort Study in England, March–July 2020
- (2020) John M. Dennis et al. DIABETES CARE
- Impact of Comorbidities and Glycemia at Admission and Dipeptidyl Peptidase 4 Inhibitors in Patients With Type 2 Diabetes With COVID-19: A Case Series From an Academic Hospital in Lombardy, Italy
- (2020) Marco Mirani et al. DIABETES CARE
- Type 1 Diabetes in People Hospitalized for COVID-19: New Insights From the CORONADO Study
- (2020) Matthieu Wargny et al. DIABETES CARE
- Relationship between obesity and severe COVID ‐19 outcomes in patients with type 2 diabetes: results from the CORONADO study
- (2020) Sarra Smati et al. DIABETES OBESITY & METABOLISM
- J-shaped association between fasting blood glucose levels and COVID-19 severity in patients without diabetes
- (2020) Bing Zhu et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Antibody response to multiple antigens of SARS-CoV-2 in patients with diabetes: an observational cohort study
- (2020) Vito Lampasona et al. DIABETOLOGIA
- Effect of chronic obstructive pulmonary disease and smoking on the outcome of COVID-19
- (2020) R. Pranata et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Insulin Treatment Is Associated with Increased Mortality in Patients with COVID-19 and Type 2 Diabetes
- (2020) Bo Yu et al. Cell Metabolism
- High admission blood glucose independently predicts poor prognosis in COVID-19 patients: A systematic review and dose-response meta-analysis
- (2020) Gilbert Lazarus et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- No significant association between dipeptidyl peptidase-4 inhibitors and adverse outcomes of COVID-19
- (2020) Jiang-Hua Zhou et al. World Journal of Clinical Cases
- Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland
- (2020) Stuart J McGurnaghan et al. Lancet Diabetes & Endocrinology
- Relationship between NK cell activity and glucose control in patients with type 2 diabetes and prediabetes
- (2019) Jung Hye Kim et al. Journal of Diabetes Investigation
- Effects of canagliflozin versus glimepiride on adipokines and inflammatory biomarkers in type 2 diabetes
- (2018) W. Timothy Garvey et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Glucagon-like Peptide-1 Receptor Agonists and Cardiovascular Events: Class Effects versus Individual Patterns
- (2018) Soo Lim et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Hepatocyte-secreted DPP4 in obesity promotes adipose inflammation and insulin resistance
- (2018) Devram S. Ghorpade et al. NATURE
- The Effect of Short-Term Hyperglycemia on the Innate Immune System
- (2016) Nagham Jafar et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- Anti-Inflammatory Effects of Metformin Irrespective of Diabetes StatusNovelty and Significance
- (2016) Amy R. Cameron et al. CIRCULATION RESEARCH
- The beneficial effects of empagliflozin, an SGLT2 inhibitor, on atherosclerosis in ApoE −/− mice fed a western diet
- (2016) Ji Hye Han et al. DIABETOLOGIA
- Acute kidney injury from SGLT2 inhibitors: potential mechanisms
- (2016) Kai Hahn et al. Nature Reviews Nephrology
- Pioglitazone after Ischemic Stroke or Transient Ischemic Attack
- (2016) Walter N. Kernan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Regulation of Chemokine Activity – A Focus on the Role of Dipeptidyl Peptidase IV/CD26
- (2016) Mieke Metzemaekers et al. Frontiers in Immunology
- Pharmacology, Physiology, and Mechanisms of Action of Dipeptidyl Peptidase-4 Inhibitors
- (2014) Erin E. Mulvihill et al. ENDOCRINE REVIEWS
- Mechanism linking diabetes mellitus and obesity
- (2014) Abdullah Algoblan et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Effects of short-term sitagliptin treatment on immune parameters in healthy individuals, a randomized placebo-controlled study
- (2013) J. D. Price et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Glucagon-Like Peptide 1 Reduces Endothelial Dysfunction, Inflammation, and Oxidative Stress Induced by Both Hyperglycemia and Hypoglycemia in Type 1 Diabetes
- (2013) A. Ceriello et al. DIABETES CARE
- Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
- (2013) V. Stalin Raj et al. NATURE
- Use of Dipeptidyl Peptidase-4 Inhibitors and the Reporting of Infections: A Disproportionality Analysis in the World Health Organization VigiBase
- (2011) M. J. Willemen et al. DIABETES CARE
- Phagocytic Activity Is Impaired in Type 2 Diabetes Mellitus and Increases after Metabolic Improvement
- (2011) Albert Lecube et al. PLoS One
- Inhibition of Monocyte Adhesion to Endothelial Cells and Attenuation of Atherosclerotic Lesion by a Glucagon-like Peptide-1 Receptor Agonist, Exendin-4
- (2010) M. Arakawa et al. DIABETES
- Management of diabetes and hyperglycemia in the hospital: A practical guide to subcutaneous insulin use in the non-critically ill, adult patient
- (2010) David Wesorick et al. Journal of Hospital Medicine
- Stress hyperglycaemia
- (2009) Kathleen M Dungan et al. LANCET
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started